dMed Completed a US$100 Million Series C Financing
News provided by
Share this article
Share this article
SHANGHAI, Dec. 17, 2020 /PRNewswire/ dMed, the clinical CRO with strong presence in China and the US, the world s two largest pharmaceutical markets and drug development sites, announced today its successful completion of a US$100 million Series C financing. Led by Fidelity Management & Research Company, LLC, new investors in dMed include Sequoia Capital China, Kaiser Foundation Hospitals and E Fund. They now join the leaders in dMed s angel, A and B rounds, Qiming Venture Partners, Lilly Asia Ventures, and Vivo Capital, which have taken most of the opportunities to increase their contributions to dMed s capital since the company s inception in 2016.
Medicare covers many health-related services, but this usually excludes dental procedures.
If a person needs dental treatments, they may need to get additional dental coverage or enroll in a Medicare Advantage plan that offers dental benefits. Kaiser Permanente (Kaiser) are an example of a Medicare Advantage plan provider who offer dental services in their plans.
This article will explore Kaiser’s plans, including the dental benefits. It will also look at coverage and costs.
We may use a few terms in this piece that can be helpful to understand when selecting the best insurance plan:
Deductible: This is an annual amount that a person must spend out of pocket within a certain time period before an insurer starts to fund their treatments.